Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Koji Hosoya"'
Autor:
Masataro Toda, Ayumi Yoshifuji, Koji Hosoya, Motoaki Komatsu, Naoki Hasegawa, Munekazu Ryuzaki
Publikováno v:
Renal Replacement Therapy, Vol 9, Iss 1, Pp 1-4 (2023)
Abstract Background Latent tuberculosis infection (LTBI) affects 11.9% of outpatients under maintenance hemodialysis in Japan. In addition, the risk of reactivation of LTBI in hemodialysis patients is up to 10–25 times higher than that in the gener
Externí odkaz:
https://doaj.org/article/cd905a18e9ef49fa84aa2cadcc5f17fb
Publikováno v:
Renal Replacement Therapy, Vol 6, Iss 1, Pp 1-7 (2020)
Abstract Background Pleuroperitoneal communication is a potential complication of peritoneal dialysis (PD). Of the various treatment strategies for pleuroperitoneal communication, successful treatment with pleurodesis using autologous blood has rarel
Externí odkaz:
https://doaj.org/article/c6f3908322714ceba55386b54f421fd9
Autor:
Keiko Fujimura, Shu Wakino, Hitoshi Minakuchi, Kazuhiro Hasegawa, Koji Hosoya, Motoaki Komatsu, Yuka Kaneko, Keisuke Shinozuka, Naoki Washida, Takeshi Kanda, Hirobumi Tokuyama, Koichi Hayashi, Hiroshi Itoh
Publikováno v:
PLoS ONE, Vol 9, Iss 4, p e94373 (2014)
We explored the renal protective effects by a gut peptide, Ghrelin. Daily peritoneal injection with Ghrelin ameliorated renal damages in continuously angiotensin II (AngII)-infused C57BL/6 mice as assessed by urinary excretion of protein and renal tu
Externí odkaz:
https://doaj.org/article/db52ef2c0ac343d7939850c0eb72cc5f
Autor:
Masataro Toda, Ayumi Yoshifuji, Koji Hosoya, Kazuaki Taguchi, Motoaki Komatsu, Emi Kobayashi, Kentaro Fujii, Ai Kato, Naoki Hasegawa, Kazuaki Matsumoto, Munekazu Ryuzaki
Publikováno v:
Journal of Infection and Chemotherapy. 28:1667-1671
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d6e4653ac9f11a6197f8a5af034a8ade
https://doi.org/10.1016/j.jiac.2022.08.011
https://doi.org/10.1016/j.jiac.2022.08.011
Autor:
Seiichi Yasuda, Ayumi Yoshifuji, Emi Kobayashi, Yoshihiko Kanno, Koji Hosoya, Munekazu Ryuzaki, Motoaki Komatsu, Akinori Hashiguchi, Shigemichi Hirose, Yuko Baba, Yuuka Hibino
Publikováno v:
Internal Medicine
A 65-year-old man with valvular disorder presented to his physician because of widespread purpura in both lower extremities. Blood tests showed elevated serum creatinine levels and proteinase 3-anti-neutrophil cytoplasmic antibody (ANCA) with hematur
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d8ce580f184ebf9a9bd09e4d98500595
https://doi.org/10.2169/internalmedicine.5608-20
https://doi.org/10.2169/internalmedicine.5608-20
Publikováno v:
Renal Replacement Therapy, Vol 6, Iss 1, Pp 1-7 (2020)
Background Pleuroperitoneal communication is a potential complication of peritoneal dialysis (PD). Of the various treatment strategies for pleuroperitoneal communication, successful treatment with pleurodesis using autologous blood has rarely been re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aa9725eebce5f5a687407616ce97c7ac
https://doi.org/10.1186/s41100-020-00273-0
https://doi.org/10.1186/s41100-020-00273-0
Autor:
Koji Hosoya, Shu Wakino, Koichi Hayashi, Hiroshi Itoh, Shuji Inoue, Naoki Washida, Keisuke Shinozuka, Kohkichi Morimoto, Takahiro Kasai
Publikováno v:
Therapeutic Apheresis and Dialysis. 19:450-456
New erythropoiesis-stimulating agents with a longer half-life have been developed for the treatment of anemia in patients with end-stage renal disease. This study evaluated the efficacy of darbepoetin alfa (DA) and long-acting epoetin beta pegol (con
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1ac4b7db70614271fd23a2a6c1ae7a0e
https://doi.org/10.1111/1744-9987.12306
https://doi.org/10.1111/1744-9987.12306
Autor:
Sana Uchikoba, Ayumi Yoshifuji, Koji Hosoya, Koji Futatsugi, Takaya Tajima, Motoaki Komatsu, Yuuka Hibino, Satoru Tatematsu, Munekazu Ryuzaki
Publikováno v:
Nihon Toseki Igakkai Zasshi. 48:663-668
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6cc91f7d38b1c69c645e6f533c27529b
https://doi.org/10.4009/jsdt.48.663
https://doi.org/10.4009/jsdt.48.663
Autor:
Munekazu Ryuzaki, Yuka Hibino, Seiichi Yasuda, Hidetomo Nakamoto, Motoaki Komatsu, Emi Kobayashi, Koji Hosoya
Publikováno v:
Nephrology Dialysis Transplantation. 33:i533-i533
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::54ffcb97749e4732ee54a937314321d6
https://doi.org/10.1093/ndt/gfy104.sp549
https://doi.org/10.1093/ndt/gfy104.sp549
Autor:
Naoki, Washida, Shuji, Inoue, Takahiro, Kasai, Keisuke, Shinozuka, Koji, Hosoya, Kohkichi, Morimoto, Shu, Wakino, Koichi, Hayashi, Hiroshi, Itoh
Publikováno v:
Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy. 19(5)
New erythropoiesis-stimulating agents with a longer half-life have been developed for the treatment of anemia in patients with end-stage renal disease. This study evaluated the efficacy of darbepoetin alfa (DA) and long-acting epoetin beta pegol (con
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::983e84dc5c8e8f5b947b92fbb3316a01
https://pubmed.ncbi.nlm.nih.gov/25944557
https://pubmed.ncbi.nlm.nih.gov/25944557